The Heidenhain Variant of Creutzfeldt-Jakob Disease
Arch Neurol 56:55-61, Kropp,S.,et al, 1999

Diffusion-Weighted MRI in Sporadic Creutzfeldt-Jakob Disease
Neurol 52:205-208, Demaerel,P.,et al, 1999

Investigation of Variant Creutzfeldt-Jakob Disease and Other Human Prion Diseases with Tonsil Biopsy Samples
Lancet 353:183-189,163, Hill,A.F.,et al, 1999

Surgical Treatment and Risk of Sporadic Creutzfeldt-Jakob Disease:A Case-Control Study
Lancet 353:693-697, Collins,S.,et al, 1999

Adult-Onset MELAS Presenting as Herpes Encephalitis
Arch Neurol 56:241-243, Sharfstein,S.R.,et al, 1999

Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999

Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999

Estrogen Use and Early Onset Alzheimer's Disease:A Population-Based Study
JNNP 67:779-781, Slooter,A.J.C.,et al, 1999

Functional Magnetic Resonance Imaging in Neuropsychiatry
BMJ 319:1551-1554, Longworth,C.,et al, 1999

Risk of Transmission of Bovine Spongiform Encephalopathy to Humans in the United States, Report of the Council on Scientific Affairs
JAMA 281:2330-2339, Tan,L.,et al, 1999

Variant Creutzfeldt-Jakob Disease
Lancet 354:317-323, Collinge,J., 1999

Dementia as the Most Common Presentation of Cortical-Basal Ganglionic Degeneration
Neurol 53:1969-1974, Grimes,D.A.,et al, 1999

Sorting Out Sleep in Patients with Alzheimer's Disease
Lancet 354:2098-2099, Foley,D., 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999

A Randomized Trial of Risperidone,Placebo,and Haloperidol for Behavioral Symptoms of Dementia
Neurol 53:946-955,899, DeDeyn,P.P.,et al, 1999

The Changing Face of Academic Neurology, Implications for Neurological Education at the Millennium*
Neurol 53:906-914, Pedley,T.A., 1999

Clinicopath Conf, Creutzfeldt-Jakob Disease,Case 28-1999
NEJM 341:901-908, , 1999

A Case of Sporadic Pick Disease With Onset at 27 Years
Arch Neurol 56:1289-1291, Jacob,J.,et al, 1999

Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999

Altered Brain Activation in Cognitively Intact Individuals at High Risk for Alzheimer's Disease
Neurol 53:1391-1396, Smith,C.D.,et al, 1999

Diagnosing Dementia with Lewy Bodies
Lancet 354:1227-1228, McKeith,I.G.,et al, 1999

Tube Feeding in Patients with Advanced Dementia,A Review of the Evidence
JAMA 282:1365-1370, Finucane,T.E.,et al, 1999

MR Angiography with Three-Dimensional Time-of-Flight and Targeted Maximum-Intensity-Projection Reconstructions in the Follow-up of Intracranial Aneurysms Embolized with Guglielmi Detachable Coils
AJNR 20:1470-1475,1391, Kahara,V.J.,et al, 1999

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999

Mild Cognitive Impairment, Clinical Characterization and Outcome
Arch Neurol 56:303-308, Petersen,R.C.,et al, 1999

Restless Legs Syndrome Improved By Pramipecole, A Double-Blind Randomized Trial
Neurol 52:938-943, Montplaisir,J.,et al, 1999

Medical Management of Epilepsy in Adults
Neurol 51:S15-S20, Mattson,R.H., 1999

Diagnosis, Management, and Treatment of Alzheimer Disease, A Guide for the Internist
Arch Int Med 159:789-798, Richards,S.S.&Hendrie,H.C., 1999

High Monounsaturated Fatty Acids Intake Protects Against Age-Related Cognitive Decline
Neurol 52:1563-1569, Solfrizzi,V.,et al, 1999

Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999

Rapidly Progressive Dementia
Lancet 353:1150, Bornke,C.,et al, 1999

Clinicopath Conf:Multisystem Neurodegenerative Disease with Dementia Pugilistica
NEJM 340:1269-1277, Case 12-1999, 1999

Practicing Neurology, A Delicate Balance
Neurol 52:1526-1532, Ringel,S.P., 1999

Advances in Cancer Pain
Arch Neurol 56:413-417, Foley,K.M., 1999

Abnormal Diffusion-Weighted Magnetic Resonance Images in Creutzfeldt-Jakob Disease
Arch Neurol 56:577-583, Bahn,M.M.,&Parchi,P., 1999

Mortality from Dementia in Occupations at Risk of Exposure to Bovine Spongiform EncephalopathyAnalysis of Death Registrations
BMJ 318:1044-1045, Aylin,P.,et al, 1999

Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999

Current Therapy for Brain Tumors, Back to the Future
Arch Neurol 56:429-432, Shapiro,W.R., 1999

Prevalence and Clinical Correlates of Psychotic Symptoms in parkinson Disease
Arch Neurol 56:595-601, Aarsland,D.,et al, 1999

Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999

Medial Temporal Lobe Atrophy on MRI in Dementia with Lewy Bodies
Neurol 52:1153-1158, Barber,R.,et al, 1999

Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999

Prion Protein Conformation in a Patient with Sporadic Fatal Insomnia
NEJM 340:1630-1638,1675, Mastrianni,J.A.,et al, 1999

Do We Have Drugs for Dementia? No
Arch Neurol 56:735-737, Pryse-Phillips,W., 1999

Do We Have a Treatment for Alzheimer Disease? Yes
Arch Neurol 56:738-739,735, Gauthier,S., 1999

Low-Density Lipoprotein Cholesterol and the Risk of Dementia with Stroke
JAMA 282:254-260, Moroney,J.T.,et al, 1999

Serial Magnetic Resonance Imaging of Cerebral Atrophy in Preclinical Alzheimer's Disease
Lancet 353:2125, Fox,N.C.,et al, 1999

Variability in Annual Mini-Mental State Examination Score in Patients with Probable Alzheimer Disease
Arch Neurol 56:857-862, Clark,C.M.,et al, 1999

Dementia Following Treatment of Brain Tumors with Radiotherapy Administered Alone or in Combination with Nitrosourea-Based Chemotherapy: A Clinical and Pathological Study
J Neurooncol 41:137-149, Vigliani,M.C.,et al, 1999